From April 1, 2022 to July 11, 2022, the company has repurchased 250,172 shares, representing 1.93% for $2.02 million. With this, the company has completed the repurchase of 520,000 shares, representing 3.98% for $7.54 million under the buyback announced on January 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.4 USD | +2.45% | -7.27% | +27.38% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.38% | 168M | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.83% | 31.75B | |
+62.86% | 26.6B | |
-21.68% | 14.41B | |
-8.73% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- GLSI Stock
- News Greenwich LifeSciences, Inc.
- Tranche Update on Greenwich LifeSciences, Inc.'s Equity Buyback Plan announced on January 24, 2022.